Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine if pumosetrag is effective in treating Gastroesophageal Reflux Disease (GERD) symptoms in patients who have a history of GERD symptoms and are currently takin...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Edusa Pharmaceuticals, Inc.
NCT05514769 · Proximal Gastric Adenocarcinoma, Gastric Cancer, and more
NCT02616302 · Gastroesophageal Reflux Disease (GERD)
NCT07121803 · Ineffective Esophageal Motility, GERD (Gastroesophageal Reflux Disease)
NCT06926374 · Colorectal Carcinoma, Rectal Prolapse, and more
NCT04506593 · Eosinophilic Esophagitis, Gastroesophageal Reflux Disease (GERD), and more
Mayo Clinic Scottsdale
Scottsdale, Arizona
Advanced Clinical Research Institute
Anaheim, California
Mayo Clinic Jacksonville
Jacksonville, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions